Companies Cryptocurrencies
Stealth BioTherapeutics Corp
Stealth BioTherapeutics Corp
Exchange: NasdaqGM
IPO Date: 15/02/2019
CEO: Ms. Irene P. McCarthy J.D.
Biotechnology Healthcare 🔗
  • MITO
  • 0.2282
  • 13685291
    market cap
  • -0.00559999
If you bought

shares of Stealth BioTherapeutics Corp (MITO) on
You would have made
Old Price $12 Current Price $12

Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company is headquartered in George Town, Grand Cayman and currently employs 57 full-time employees. The firm is primarily focused on developing mitochondrial targeted therapies for diseases with clear unmet medical needs including cardiovascular, renal, neurodegenerative and metabolic diseases. The firm is engaged in developing its product pipelines, which include Elamipretide, SBT-20 and SBT-272.

Address: 190 Elgin Avenue George Town GEORGE TOWN GRAND CAYMAN KY1-9005

Stay updated.